Literature DB >> 18622762

Connective tissue growth factor (CTGF) and cancer progression.

Chia-Yu Chu1, Cheng-Chi Chang, Ekambaranellore Prakash, Min-Liang Kuo.   

Abstract

Connective tissue growth factor (CTGF) is a member of the CCN family of secreted, matrix-associated proteins encoded by immediate early genes that play various roles in angiogenesis and tumor growth. CCN family proteins share uniform modular structure which mediates various cellular functions such as regulation of cell division, chemotaxis, apoptosis, adhesion, motility, angiogenesis, neoplastic transformation, and ion transport. Recently, CTGF expression has been shown to be associated with tumor development and progression. There is growing body of evidence that CTGF may regulate cancer cell migration, invasion, angiogenesis, and anoikis. In this review, we will highlight the influence of CTGF expression on the biological behavior and progression of various cancer cells, as well as its regulation on various types of protein signals and their mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622762     DOI: 10.1007/s11373-008-9264-9

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  58 in total

1.  Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.

Authors:  Vanisri Raviraj; Hui Zhang; Hsin-ya Chien; Louise Cole; Erik W Thompson; Lilian Soon
Journal:  Clin Exp Metastasis       Date:  2012-01-22       Impact factor: 5.150

2.  Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.

Authors:  Haijun Zhang; Fanyan Meng; Gang Liu; Bin Zhang; Jun Zhu; Feng Wu; Stephen P Ethier; Fred Miller; Guojun Wu
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

3.  Six1 promotes glioblastoma cell proliferation and invasion by upregulation of connective tissue growth factor.

Authors:  Tian Tian; Aimin Li; Hong Lu; Ran Luo; Mingzhi Zhang; Zhaoming Li
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

4.  Identification of core miRNA based on small RNA-seq and RNA-seq for colorectal cancer by bioinformatics.

Authors:  Youwei Kou; Lei Qiao; Qiang Wang
Journal:  Tumour Biol       Date:  2014-11-21

5.  Mass spectrometry-based proteomic analysis of the matrix microenvironment in pluripotent stem cell culture.

Authors:  Chris Hughes; Lida Radan; Wing Y Chang; William L Stanford; Dean H Betts; Lynne-Marie Postovit; Gilles A Lajoie
Journal:  Mol Cell Proteomics       Date:  2012-09-27       Impact factor: 5.911

6.  CTGF is a therapeutic target for metastatic melanoma.

Authors:  E C Finger; C-F Cheng; T R Williams; E B Rankin; B Bedogni; L Tachiki; S Spong; A J Giaccia; M B Powell
Journal:  Oncogene       Date:  2013-02-25       Impact factor: 9.867

7.  CCN6 (WISP3): a new anti-cancer therapy?

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2010-11-09       Impact factor: 5.782

8.  Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma.

Authors:  Mei-Hong Li; Rolf Swenson; Miriam Harel; Sampa Jana; Erik Stolarzewicz; Timothy Hla; Linda H Shapiro; Fernando Ferrer
Journal:  J Pharmacol Exp Ther       Date:  2015-06-23       Impact factor: 4.030

9.  Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth.

Authors:  Ming Xiu; Ya-Hui Liu; David R Brigstock; Fang-Hui He; Rui-Juan Zhang; Run-Ping Gao
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

10.  Inhibition of connective tissue growth factor (CTGF/CCN2) in gallbladder cancer cells leads to decreased growth in vitro.

Authors:  Patricia Garcia; Pamela Leal; Carmen Ili; Priscilla Brebi; Hector Alvarez; Juan C Roa
Journal:  Int J Exp Pathol       Date:  2013-04-18       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.